This topic contains a solution. Click here to go to the answer

Author Question: In an experiment, if one group is asked to pretend that they were exposed to one of the levels of ... (Read 101 times)

jjjetplane

  • Hero Member
  • *****
  • Posts: 556
In an experiment, if one group is asked to pretend that they were exposed to one of the levels of the independent variable and behave as if they had been exposed to it when they had actually not been, this group would be called a
 
  A) nave experimental group.
  B) simulation control group.
  C) stooge group.
  D) know-nothing control group.

Question 2

In the text the author discusses in great detail procedures such as the use of placebos, double-blind designs, and automation. These were all suggested to counteract the possible effects of
 
  A) demand characteristics.
  B) non-cooperative participants.
  C) defensive participants.
  D) cheating.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

LVPMS

  • Sr. Member
  • ****
  • Posts: 323
Answer to Question 1

B

Answer to Question 2

A




jjjetplane

  • Member
  • Posts: 556
Reply 2 on: Jun 19, 2018
:D TYSM


Dinolord

  • Member
  • Posts: 313
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

Limit intake of red meat and dairy products made with whole milk. Choose skim milk, low-fat or fat-free dairy products. Limit fried food. Use healthy oils when cooking.

Did you know?

Patients should never assume they are being given the appropriate drugs. They should make sure they know which drugs are being prescribed, and always double-check that the drugs received match the prescription.

Did you know?

Interferon was scarce and expensive until 1980, when the interferon gene was inserted into bacteria using recombinant DNA technology, allowing for mass cultivation and purification from bacterial cultures.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

Critical care patients are twice as likely to receive the wrong medication. Of these errors, 20% are life-threatening, and 42% require additional life-sustaining treatments.

For a complete list of videos, visit our video library